Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Gynecologic Oncology
|
July 1, 1995
Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix
R G Pearcey, G C Stuart, G D MacLean, et al.
The International Journal of Biological Markers
|
January 1, 1991
Possible utility of serum determinations of CA 125 and CA 27.29 in breast cancer management
J L Jensen, G D Maclean, M R Suresh, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
May 1, 1992
Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen
G D MacLean, M B Bowen-Yacyshyn, J Samuel, et al.
Bone Marrow Transplantation
|
June 29, 2000
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine
L A Holmberg, D V Oparin, T Gooley, et al.
Nuclear Medicine Communications
|
January 1, 1992
MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with 99Tcm and with 111In
A J McEwan, G D MacLean, H R Hooper, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Gynecologic Oncology
|
July 1, 1995
Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix
R G Pearcey, G C Stuart, G D MacLean, et al.
The International Journal of Biological Markers
|
January 1, 1991
Possible utility of serum determinations of CA 125 and CA 27.29 in breast cancer management
J L Jensen, G D Maclean, M R Suresh, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
May 1, 1992
Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen
G D MacLean, M B Bowen-Yacyshyn, J Samuel, et al.
Bone Marrow Transplantation
|
June 29, 2000
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine
L A Holmberg, D V Oparin, T Gooley, et al.
Nuclear Medicine Communications
|
January 1, 1992
MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with 99Tcm and with 111In
A J McEwan, G D MacLean, H R Hooper, et al.
Page
of 5